help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Graves, S. W.
Right arrow Articles by Williams, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Graves, S. W.
Right arrow Articles by Williams, G. H.

Journal of Clinical Endocrinology & Metabolism, Vol 59, 1070-1074, Copyright © 1984 by Endocrine Society

ARTICLES

An endogenous ouabain-like factor associated with hypertensive pregnant women

SW Graves and GH Williams

Levels of a ouabain-like factor (OLF) were measured in amniotic fluid from 49 undigitalized third trimester pregnant women by means of its cross-reactivity in a digoxin RIA and its inhibition of ouabain- sensitive [Na,K]ATPase. The results from these 2 assays were significantly correlated (P less than 0.05). Of the women included in this study, 25 had blood pressures considered normal for their gestational age, while 24 had developed during their current pregnancy blood pressures judged to be elevated. When levels of OLF in the amniotic fluids from the normotensive and hypertensive pregnant women were compared, significantly higher levels were present in the hypertensive group for both assays (P less than 0.002). Further, there was a significant correlation between the diastolic blood pressures of these women at the time of amniocentesis and the amniotic fluid OLF levels determined by either assay (P less than 0.002). These results are consistent with OLF having a role in hypertensive complications of pregnancy.


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
G. Pridjian, C. Pridjian, S. Danchuk, M. Ianosi-Irimie, H. V. Vu, and J. B. Puschett
Beneficial Effects of Metolazone in a Rat Model of Preeclampsia
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1027 - 1032.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
H. Vu, M. Ianosi-Irimie, S. Danchuk, E. Rabon, T. Nogawa, Y. Kamano, G. R. Pettit, T. Wiese, and J. B. Puschett
Resibufogenin Corrects Hypertension in a Rat Model of Human Preeclampsia
Experimental Biology and Medicine, February 1, 2006; 231(2): 215 - 220.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
H. Tamura, S. Shimoyama, Y. Sunaga, M. Sakaguchi, and T. Kuroume
Digoxin-Like Immunoreactive Substance in Urine of Patients with Mucocutaneous Lymph Node Syndrome (MCLS)
Angiology, October 1, 1992; 43(10): 856 - 865.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1984 by The Endocrine Society